MedTrace Logo

Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants

NCT02073071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2015-11-30

No results posted yet for this study

Summary

This is a two stage open-label, single-arm, multicenter and observational study.

Conditions

  • Other Preterm Infants

Interventions

OTHER

Preterm infant formula per standard of care

Commercially available preterm infant formula

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Xianfeng Zhao, MD, PhD · Abbott Nutrition China

Eligibility

Max Age
21 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-09-30
Completion
2015-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02073071 on ClinicalTrials.gov